Good Simulation
Practice.
Toward Good
Simulation Practice
Published Open Access on Springer Nature
A crucial document guiding the use of simulation data & evidence in the regulatory process of biomedical products.
InSilicoTrials is thrilled to announce the publication of Toward Good Simulation Practice — Best practices for the use of computational modelling & simulation in the regulatory process of biomedical products, a crucial document guiding the use of simulation data & evidence in the regulatory process of biomedical products.
This work is the culmination of a global collaboration among in silico experts, coordinated by the In Silico World consortium, with significant contributions from the Avicenna Alliance, VPH Institute, and FDA professionals.
Published in open access by Springer Nature Group, the book is edited by Prof. Marco Viceconti and InSilicoTrials' CEO Luca Emili, addressing the need for standardized practices within the in silico field.
Pras Pathmanathan
Office of Science and Engineering Laboratories
Center for Devices and Radiological Health · FDA
… it is hoped that this book will stimulate further conversations amongst all stakeholders and ultimately contribute to the development of community–accepted Good Simulation Practice, bringing M&S for medical products to maturity.
A global collaboration.
From book
to practice.
If you're seeking more details or interested in exploring how this groundbreaking publication can enhance your biosimulation strategies, don't hesitate to get in touch. Our InSilicoTrials experts are ready to assist you in understanding the implications of Good Simulation Practice (GSP) for your projects, illustrating best practices, and demonstrating use cases to maximize GSP's benefits for your drug development endeavors.
◆ Talk to our experts